{"id":41105,"key":"Global_Health_Medical_Device_Compendium/VeraLight_Scout_DS","title":"Global Health Medical Device Compendium/VeraLight Scout DS","latest":{"id":1267720,"timestamp":"2026-09-10T14:17:25Z"},"content_model":"wikitext","license":{"url":"https://www.appropedia.org/Appropedia:Copyrights","title":"CC-BY-SA-4.0"},"source":"[[File:Veralight.jpg|thumb]]\n\n{{GHMDC device data\n| health-topic = Type II Diabetes\n| classification = Diagnosis\n| scope = Commercialized\n| manufacturer-location = New Mexico, United States\n}}\n\nDiabetes Mellitus is a growing world-wide problem. Half of the current cases in the developing world go undetected for 5-9 years after onset, leading to irreversible damage. Current diagnostic techniques are invasive and inconvenient due to weak test sensitivity and the need for drawing blood.\n\n== Detailed description of the solution ==\n\nThe Scout DS is a completely non-invasive device used to detect pre-diabetes and type II diabetes in adults. The patient simply places his or her arm on a portable table device, which accurately measures skin biomarkers such as Advanced Glycation End Products, metabolic and microvascular changes.\n\n== Relevance to Developing Country Settings ==\n\nThis device is particularly beneficial for developing world context because it provides a prompt indication of whether or not a person likely has diabetes without the need for blood.\n\n== Designed/Manufactured by ==\n\n* Manufacturer: VeraLight, Inc.\n* Manufacturer location: Albuquerque, New Mexico, United States\n\n \n\n== Funding Source ==\n\nVeraLight is a privately-funded company that was founded in 2004 in order to develop the Scout DS technology.\n\n== References ==\n\n=== Peer-reviewed publication ===\n\nEdiger, M. N., Olson, B. P., & Maynard, J. D. (2009). Noninvasive optical screening for diabetes. Journal of Diabetes Science and Technology, 3(4), 776-780.\n\n=== Internally generated reports ===\n\nCavanaugh, B., Matter, N., Way, J., Maynard, J. Noninvasive Skin Intrinsic Fluorescence Correlates With Degree of Coronary Artery Calcification. VeraLight. PDF available [http://veralight.cn/media/docs/2011/SCCT_poster_01_071211.pdf here].\n\n=== Externally generated reports ===\n\nHeubeck, E. (October, 2007). Noninvasive Diabetes Screening Tool Shows Potential. DOC News, Vol. 4 No. 10 7. Link available [http://docnews.diabetesjournals.org/content/4/10/7.short here].\n\n=== Approval by regulatory bodies or standards boards ===\n\nScout DS has received CE and Health Canada approval for commercial distribution. It has not yet received FDA approval.\n\n{{Page data\n| sdg = SDG03 Good health and well-being, SDG09 Industry innovation and infrastructure\n| license = CC-BY-SA-3.0\n| language = en\n| description = VeraLight Scout DS detects diabetes without needles. Appropedia shares how this tool helps early diagnosis in low-resource settings.\n}}"}